Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Omnicell Inc (OMCL)
Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,335,093
  • Shares Outstanding, K 45,081
  • Annual Sales, $ 1,296 M
  • Annual Income, $ 5,650 K
  • 60-Month Beta 0.89
  • Price/Sales 2.54
  • Price/Cash Flow 17.51
  • Price/Book 2.90
Trade OMCL with:

Options Overview Details

View History
  • Implied Volatility 45.89% ( -2.33%)
  • Historical Volatility 51.90%
  • IV Percentile 46%
  • IV Rank 38.14%
  • IV High 79.43% on 02/27/23
  • IV Low 25.20% on 08/19/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 3,262
  • Open Int (30-Day) 3,954

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.01
  • Number of Estimates 5
  • High Estimate 0.01
  • Low Estimate -0.03
  • Prior Year 0.50
  • Growth Rate Est. (year over year) -102.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.00 +19.32%
on 05/03/23
76.15 -2.85%
on 05/23/23
+15.52 (+26.55%)
since 05/02/23
3-Month
50.00 +47.96%
on 03/13/23
76.15 -2.85%
on 05/23/23
+16.54 (+28.80%)
since 03/02/23
52-Week
46.11 +60.44%
on 12/20/22
125.17 -40.90%
on 06/28/22
-36.26 (-32.89%)
since 06/02/22

Most Recent Stories

More News
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO

/PRNewswire/ -- EmpiRx Health, the industry's only value-based PBM, today announced that the company's president, Danny Sanchez, has been named Chief Executive...

OMCL : 73.98 (+1.45%)
Omnicell's (OMCL) New Acquisitions Aid Growth, Cost Woes Stay

Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.

JNJ : 156.97 (+1.57%)
ISRG : 312.18 (+0.53%)
EW : 85.34 (+0.13%)
OMCL : 73.98 (+1.45%)
Omnicell to Present at the BofA Securities 2023 Healthcare Conference

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference...

OMCL : 73.98 (+1.45%)
Encompass Health's (EHC) Q1 Earnings Beat, '23 EPS View Up

Encompass Health's (EHC) Q1 results reflect improved patient volumes and higher discharge growth. Management estimates 2023 adjusted EPS within $2.94-$3.23, up from the earlier view of $2.87-$3.16.

OMCL : 73.98 (+1.45%)
IDXX : 470.83 (+0.21%)
ZBH : 129.81 (+1.92%)
EHC : 62.74 (+0.71%)
Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Down

Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.

OMCL : 73.98 (+1.45%)
JNJ : 156.97 (+1.57%)
ISRG : 312.18 (+0.53%)
EW : 85.34 (+0.13%)
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of 457.14% and 4.96%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

OMCL : 73.98 (+1.45%)
NVTA : 1.0700 (+0.94%)
Omnicell: Q1 Earnings Snapshot

Omnicell: Q1 Earnings Snapshot

OMCL : 73.98 (+1.45%)
Omnicell Announces First Quarter 2023 Results

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results...

OMCL : 73.98 (+1.45%)
Autolus (AUTL) Selects Cardinal Health for Cell Therapy Supply

Autolus (AUTL) partners with Cardinal Health to bring next-generation CAR-T cell therapies to the market and revolutionize cancer treatment.

CAH : 84.59 (+1.40%)
OMCL : 73.98 (+1.45%)
SYNH : 41.56 (+0.02%)
AUTL : 2.90 (-7.35%)
NextGen's (NXGN) Behavioral Health Suite Adopted by Mindful Care

NextGen's (NXGN) Behavioral Health Suite is expected to facilitate Mindful Care's ability to offer same-day appointments via online scheduling.

OMCL : 73.98 (+1.45%)
TRHC : 5.57 (+2.39%)
SYNH : 41.56 (+0.02%)
NXGN : 16.19 (+3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 75.98
2nd Resistance Point 75.19
1st Resistance Point 74.59
Last Price 73.98
1st Support Level 73.20
2nd Support Level 72.41
3rd Support Level 71.81

See More

52-Week High 125.17
Fibonacci 61.8% 94.97
Fibonacci 50% 85.64
Fibonacci 38.2% 76.31
Last Price 73.98
52-Week Low 46.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar